KATHLEEN LEDWICK: Open Payments
NPI 1679896351 · MANCHESTER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,372 in 43 payments from 13 companies in 2025. Trend: 2023 $308 · 2024 $802 · 2025 $1,372
Food & beverage: $1,372
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $468 |
| Galderma Laboratories, L.P. | 6 | $202 |
| Janssen Biotech, Inc. | 4 | $189 |
| GENZYME CORPORATION | 3 | $158 |
| Incyte Corporation | 3 | $81 |
| Organon LLC | 6 | $72 |
| Arcutis Biotherapeutics, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 2 | $29 |
Products named: OTEZLA, TREMFYA, DUPIXENT, NEMLUVIO, OPZELURA, VTAMA, Zoryve, Sotyktu.
Industry payments across NH — which companies pay providers there.
